Cat. No.: X24-08-YM331
Kinesin inhibitor, Kif15-IN-2, Purity ≥98%
Synonym: 672926-33-9; (2S)-2-(2,4-Dioxo-1H-quinazolin-3-yl)-3-methyl-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-2-yl]butanamide
- CAS Number: 672926-33-9
- Compound CID: 60076305
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Properties
Description
Kif15-IN-2 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting kinesin.
Molecular Formula
C20H20N6O4S
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
Kif15-IN-2 is a cytoskeletal signaling inhibitor that can be used for its potential to affect mitosis and cell division, making it a candidate for cancer treatment by impairing spindle assembly and function in tumor cells.
Related Products
-
Kinesin inhibitor, Ispinesib, Purity ≥98%
-
Kinesin inhibitor, SB 743921, Purity ≥98%
-
Kinesin inhibitor, Arry-520, Purity ≥98%
-
Kinesin inhibitor, AZ 3146, Purity ≥98%
-
Kinesin inhibitor, GSK-923295, Purity ≥98%
-
Kinesin inhibitor, Monastrol, Purity ≥98%